The invention provides novel polycyclic macrolactones which can be produced, in particular, by a representative of the bacterial genus
Verrucosispora
. These substances are preferentially distinguished by their pharmacological effect. In particular, they exhibit an antibiotic effect. This antibiotic effect is preferably directed against Gram-positive bacteria.